Ad
related to: UTHR
Search results
IBD Stock Of The Day United Therapeutics Is Braving Competition, And Eyeing Two Entries
Investor's Business Daily· 1 year agoUnited Therapeutics is the IBD Stock Of The Day as competition heats up in its bread-and-butter lung...
United Therapeutics (UTHR) Initiates Tyvaso Study in IPF
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics (UTHR) initiates a second phase III study evaluating its Tyvaso inhalation...
Here's Why United Therapeutics (UTHR) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
ASRT or UTHR: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance· 1 year agoInvestors with an interest in Medical - Drugs stocks have likely encountered both Assertio (ASRT)...
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 year agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
United Therapeutics (UTHR) Q2 Earnings Miss Estimates, Revenues Up
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics' (UTHR) second-quarter earnings missed estimates, while sales beat the same....
After Plunging -5.18% in 4 Weeks, Here's Why the Trend Might Reverse for United Therapeutics (UTHR)
Zacks via Yahoo Finance· 1 year agoUnited Therapeutics (UTHR) is technically in oversold territory now, so the heavy selling pressure...
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics (UTHR) doesn't possess the right combination of the two key ingredients for a...
United Therapeutics Corporation's (NASDAQ:UTHR) Intrinsic Value Is Potentially 98% Above Its Share...
Simply Wall St. via Yahoo Finance· 1 year agoToday we will run through one way of estimating the intrinsic value of United Therapeutics...
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
Zacks via Yahoo Finance· 2 months agoUnited Therapeutics‘ UTHR fourth-quarter 2023 earnings of $4.36 per share beat the Zacks Consensus...